Disseminated intravascular coagulation at presentation of advanced gastric cancer

Israel Medical Association Journal

Volumn 8, Issue 12, 2006, Pages 853-855

  Tokar, Margarita ^a   Bobilev, Dmitri ^a   Ariad, Samuel ^a   Geffen, David B ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

5 fluorouracil; Bone marrow involvement; Bone metastases; Disseminated intravascular coagulation; Gastric cancer

Indexed keywords

CISPLATIN; DOCETAXEL; EPIRUBICIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; ARTICLE; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; BONE METASTASIS; CANCER SURVIVAL; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG INFUSION; DRUG RESPONSE; FATALITY; FEMALE; HUMAN; LABORATORY TEST; MULTIPLE CYCLE TREATMENT; STOMACH BIOPSY; STOMACH CANCER; SURVIVAL TIME;

ACUTE DISEASE; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; BONE MARROW NEOPLASMS; CISPLATIN; DISEASE PROGRESSION; DISSEMINATED INTRAVASCULAR COAGULATION; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33845878511     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55(1):10-30.
2. Pyrhonen S, Kuitunen T, Nyandoto, P. Kouri M, Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 1995;71(3):587-91.
3. Murad AM, Santiago FF, Petroianu A, Rocha PR, Rodrigues MA, Rausch M. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 1993;72(1):37-41.
4. Schipper DL, Wagener DJ. Chemotherapy of gastric cancer [Review]. Anticancer Drugs 1996;7(2):137-49.
5. Glimelius B, Ekstrom K. Hoffman K, et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 1997; 8(2):163-8.
6. Pasquini E, Gianni L, Aitini E, et al. Acute disseminated intravascular coagulation syndrome in cancer patients. Oncology 1995; 52(6):505-8.
7. Yeh KH, Cheng AL, Gastric cancer associated with acute disseminated intravascular coagulation: successful initial treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin. Br J Haematol 1998;100(4):769-72.
8. Chao Y, Teng HC, Hung HC, et al. Successful initial treatment with weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin chemotherapy in advanced gastric cancer patients with disseminated intravascular coagulation. lpn J Clin Oncol 2000;30(3): 122-5.
9. Carvalho R, Milne AN, van Rees BP, et al. Early-onset gastric carcinomas display molecular characteristics distinct from gastric carcinomas occurring at a later age. J Pathol 2004;204(1):75-83.
10. Sulkes A. Chemotherapy in gastric cancer: a brief chronicle with emphasis on recent developments [Review]. IMAI 2004;6(7):415-19.
11. Webb A, Cunningham D, Scarffe JH, et al. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastdc cancer. J Clin Oncol 1997;15(1):261-7.
12. Ross P, Nicolson M, Cunningham D, et al. Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 2002;20(8):1996-2004.
13. Shah MA, Schwartz GK. Treatment of metastatic esophagus and gastric cancer [Review]. Semin Oncol 2004;31(4):574-87.
14. Van Cutsem E. The treatment of advanced gastric cancer: new findings on the activity of the taxanes [Review]. Oncologist 2004;9 (Suppl 2):9-15.